Tonix Pharmaceuticals Holding (FRA:TPM0) Other Income (Expense) : €5.91 Mil (TTM As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Tonix Pharmaceuticals Holding Other Income (Expense)?

Tonix Pharmaceuticals Holding's other income expense for the Tonix Pharmaceuticals Holding's pretax income for the three months ended in Mar. 2024 was €5.90 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2024 was €5.91 Mil.

Tonix Pharmaceuticals Holding Other Income (Expense) Historical Data

The historical data trend for Tonix Pharmaceuticals Holding's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tonix Pharmaceuticals Holding Other Income (Expense) Chart

Tonix Pharmaceuticals Holding Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Income (Expense)

Get a 7-Day Free Trial

1.58

Tonix Pharmaceuticals Holding Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Income (Expense)	Get a 7-Day Free Trial															-	-	-	0.01	5.90

Tonix Pharmaceuticals Holding Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €5.91 Mil.

Tonix Pharmaceuticals Holding (FRA:TPM0) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Tonix Pharmaceuticals Holding (FRA:TPM0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tonix Pharmaceuticals Holding Corp (FRA:TPM0) » Definitions » Other Income (Expense)

Comparable Companies

Traded in Other Exchanges

TNXP:USA

Address

26 Main Street, Suite 101, Chatham, NJ, USA, 07928

Website

https://www.tonixpharma.com

Tonix Pharmaceuticals Holding Corp is a clinical-stage biopharmaceutical company focused on developing therapeutics and vaccines to treat and prevent human disease and alleviate suffering. its portfolio consists of the central nervous system, rare disease, immunology, and infectious disease product candidates. The CNS portfolio includes small molecules and biologics to treat pain, neurologic, psychiatric, and addiction conditions. CNS product candidate is TNX-102 SL, a proprietary sublingual tablet formulation of cyclobenzaprine (CBP) designed for bedtime administration.

Tonix Pharmaceuticals Holding (FRA:TPM0) Headlines

No Headlines